| Margaret C Mcbride, MD | |
|
1 Perkins Sq, Akron, OH 44308-1063 | |
| (330) 543-8050 | |
| (330) 543-8054 |
| Full Name | Margaret C Mcbride |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Neurology With Special Qualifications In Child Neurology |
| Location | 1 Perkins Sq, Akron, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003903030 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0402X | Psychiatry & Neurology - Neurology With Special Qualifications In Child Neurology | 35-077004 (Ohio) | Primary |
| Entity Name | Children's Hospital Medical Center Of Akron |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841328853 PECOS PAC ID: 0648183012 Enrollment ID: O20031111000484 |
News Archive
Roche announced today the global launch of a new software update that significantly extends the range of amplicon lengths available for targeted next-generation sequencing studies on the 454 GS FLX+ System.
Endocrinologists, primary care physicians (PCPs) and nurse educators perceive Lilly and Novo Nordisk to have the best diabetes corporate image, with Lilly slightly outscoring Novo among endocrinologists and Novo outscoring Lilly among PCPs and nurses. Results show that endocrinologists see wider differences among the diabetes companies in overall image and key performance dimensions more so than do PCPs and nurses, according to Market Strategies International's syndicated 2010 U.S. Diabetes MSImage® study.
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing new drugs for the treatment of unmet medical needs, announced today that it has begun to enroll patients in a Phase I/II clinical trial of its lead drug candidate trans sodium crocetinate (TSC).
GE Healthcare and Vanderbilt University Medical Center today announced a five-year partnership to enable safer and more precise cancer immunotherapies. Multiple diagnostic tools will be developed to help predict both the efficacy of an immunotherapy treatment and its adverse effects for a specific patient before the therapy is administered.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Margaret C Mcbride, MD 1 Perkins Sq, Akron, OH 44308-1063 Ph: (330) 543-8050 | Margaret C Mcbride, MD 1 Perkins Sq, Akron, OH 44308-1063 Ph: (330) 543-8050 |
News Archive
Roche announced today the global launch of a new software update that significantly extends the range of amplicon lengths available for targeted next-generation sequencing studies on the 454 GS FLX+ System.
Endocrinologists, primary care physicians (PCPs) and nurse educators perceive Lilly and Novo Nordisk to have the best diabetes corporate image, with Lilly slightly outscoring Novo among endocrinologists and Novo outscoring Lilly among PCPs and nurses. Results show that endocrinologists see wider differences among the diabetes companies in overall image and key performance dimensions more so than do PCPs and nurses, according to Market Strategies International's syndicated 2010 U.S. Diabetes MSImage® study.
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing new drugs for the treatment of unmet medical needs, announced today that it has begun to enroll patients in a Phase I/II clinical trial of its lead drug candidate trans sodium crocetinate (TSC).
GE Healthcare and Vanderbilt University Medical Center today announced a five-year partnership to enable safer and more precise cancer immunotherapies. Multiple diagnostic tools will be developed to help predict both the efficacy of an immunotherapy treatment and its adverse effects for a specific patient before the therapy is administered.
› Verified 8 days ago
Dr. Marnie Alexandra Mcgrath, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 444 N Main St, #400, Akron, OH 44310 Phone: 330-344-6440 | |
Thiruvengadam Kulasekaran, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 Locust St, Suite 150, Akron, OH 44302 Phone: 330-253-2113 Fax: 330-253-2362 | |
Ann Christina Ciancone, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, Akron, OH 44333 Phone: 330-665-8168 Fax: 330-665-8087 | |
Sumru Bilge-johnson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 215 W Bowery St, Akron, OH 44308 Phone: 330-543-4382 Fax: 330-543-3856 | |
Dr. Christopher Michael Durner, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 444 N Main St, Akron, OH 44310 Phone: 330-379-5235 Fax: 330-379-9226 | |
Dr. Eileen M Schwartz, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 150 Cross Street, Akron, OH 44311 Phone: 330-253-9388 Fax: 330-376-6726 |